Follow us:

Pradaxa Back in the Advertising Game

Posted on

PradaxaAfter conducting a heavy television advertising campaign in 2014, the anticoagulant drug Pradaxa is launching a new series of advertisements to compete for market share with big spenders Eliquis and Xarelto, who are saturating the airwaves with $75-$100 million worth of advertising each.

Different Medications, Different Advertising Approaches

 

The three big spending brands now have very different creative approaches:

Xarelto and Eliquis spend over $200 million a year on advertising, and Pradaxa’s reentry will only add to that total. Experts say that Pradaxa will need to spend a minimum of $50 million to gain a competitive share of voice to be heard.

What Do Anticoagulants Do?

Anticoagulants like Pradaxa, Eliquis, and Xarelto belong to the stroke category of medications, which were approved by the U.S. Food and Drug Administration (FDA) to:

Anticoagulants work by interrupting the process involved in the formation of blood clots. Although they’re sometimes called blood thinners, these medications don’t actually make the blood thinner. Rather, anticoagulants prevent blood clots from forming by preventing red blood cells, platelets, fibrin, and white blood cells from sticking together to form a clot.

Contact Us

If you have suffered uncontrollable bleeding or if your loved one lost life due to bleeding after taking Pradaxa we can help. Contact the attorneys of Childers, Schlueter & Smith for a free case evaluation and consultation to learn more about your legal rights and options. Our experienced drug injury lawyers will work closely with you and fight for the maximum compensation for your injuries.

Tags: , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *